|
|
| | Esorubicin Basic information |
| Product Name: | Esorubicin | | Synonyms: | Esorubicin;5,12-Naphthacenedione, 10-(2S,4R,6S)-4-aminotetrahydro-6-methyl-2H-pyran-2-yloxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-;4'-deoxydoxorubicin;(8S,10S)-10-[[(2S)-4α-Aminotetrahydro-6α-methyl-2H-pyran-2β-yl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;4'-Deoxyadriamycin;5,12-Naphthacenedione, 10-[[(2S,4R,6S)-4-aminotetrahydro-6-methyl-2H-pyran-2-yl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)- | | CAS: | 63521-85-7 | | MF: | C27H29NO10 | | MW: | 527.52 | | EINECS: | | | Product Categories: | | | Mol File: | 63521-85-7.mol |  |
| | Esorubicin Chemical Properties |
| Boiling point | 765.8±60.0 °C(Predicted) | | density | 1.55±0.1 g/cm3(Predicted) | | pka | 7.35±0.60(Predicted) |
| | Esorubicin Usage And Synthesis |
| | Esorubicin Preparation Products And Raw materials |
|